Home › Asset managers › Gabelli › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Gabelli voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
490 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Gabelli voted | Funds |
|---|---|---|---|---|---|---|
| MIND TECHNOLOGY, INC. | 2025-07-17 | APPROVAL OF THE FIFTH AMENDMENT TO THE STOCK AWARDS PLAN | Compensation | Board | ABSTAIN | 1 |
| MIND TECHNOLOGY, INC. | 2025-07-17 | RATIFICATION OF THE SELECTION OF MOSS ADAMS LLP AS MIND TECHNOLOGY INC'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JANUARY 31, 2026 | Audit-related | Board | ABSTAIN | 1 |
| MKS, INC. | 2026-05-11 | The approval of the Amended and Restated 2022 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 |
| MODERNA, INC. | 2025-11-12 | To approve a one-time stock option exchange program for non- Executive Committee employees of Moderna, Inc. (the "Option Exchange Proposal"). | Capital Structure | Board | AGAINST | 1 |
| MONDELEZ INTERNATIONAL, INC. | 2026-05-20 | Shareholder proposal requesting a report on objective evaluation of plastics packaging policies | Environment or Climate | Shareholder | FOR | 1 |
| MORGAN STANLEY | 2026-05-14 | To ratify the appointment of Deloitte & Touche LLP as independent auditor | Audit-related | Board | AGAINST | 1 |
| NASDAQ, INC. | 2026-06-10 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 | Audit-related | Board | AGAINST | 1 |
| NEKTAR THERAPEUTICS | 2026-06-04 | To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. | Compensation | Board | AGAINST | 1 |
| NEUROCRINE BIOSCIENCES, INC. | 2026-05-27 | To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; and | Compensation | Board | ABSTAIN | 1 |
| NEURONETICS, INC. | 2026-05-28 | Approval of the Neuronetics, Inc. 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| NEW HOPE CORPORATION LTD | 2025-11-20 | APPROVAL OF THE COMPANYS RIGHTS PLAN | Compensation | Board | AGAINST | 1 |
| NEW JERSEY RESOURCES CORPORATION | 2026-01-21 | To approve the 2026 Stock Award and Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| NISSIN FOODS COMPANY LIMITED | 2026-06-03 | TO EXTEND THE GENERAL MANDATE TO BE GIVEN TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES OF AN AMOUNT REPRESENTING THE TOTAL NUMBER OF SHARES BOUGHT BACK BY THE COMPANY | Capital Structure | Board | AGAINST | 1 |
| NISSIN FOODS COMPANY LIMITED | 2026-06-03 | TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ISSUE NEW SHARES NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY | Capital Structure | Board | AGAINST | 1 |
| NN, INC. | 2026-05-20 | Approval of the Amended and Restated 2022 Omnibus Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| NOVUS HOLDINGS LIMITED | 2025-08-22 | ENDORSEMENT OF THE REMUNERATION POLICY | Compensation | Board | AGAINST | 1 |
| NOVUS HOLDINGS LIMITED | 2025-08-22 | RE-ELECTION OF NON-EXECUTIVE DIRECTOR - ADRIAN STEVEN ZETLER | Director Elections | Board | AGAINST | 1 |
| NVIDIA CORPORATION | 2026-06-24 | Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2027. | Audit-related | Board | AGAINST | 1 |
| OCEANFIRST FINANCIAL CORP. | 2026-05-27 | Approval of the OceanFirst Financial Corp. 2026 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 |
| OPKO HEALTH, INC. | 2026-06-18 | To approve the Company's 2026 Equity Incentive Plan; | Compensation | Board | AGAINST | 1 |
| ORACLE CORPORATION | 2025-11-18 | Ratification of the Selection of our Independent Registered Public Accounting Firm | Audit-related | Board | AGAINST | 1 |
| OTIS WORLDWIDE CORPORATION | 2026-05-27 | Shareholder proposal regarding reporting on political contributions and expenditures | Other Social Issues | Shareholder | FOR | 1 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 2026-06-03 | To approve the amendment of our 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| PACIFIC PREMIER BANCORP, INC. | 2025-07-21 | Approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to the named executive officers of Pacific Premier in connection with the transactions contemplated by the merger agreement. | Say-on-Pay | Board | AGAINST | 1 |
| PEPSICO, INC. | 2026-05-06 | Ratification of appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025. | Audit-related | Board | AGAINST | 1 |
| PROLOGIS, INC. | 2026-04-28 | Ratification of the Appointment of KPMG LLP as the Company's Independent Registered Public Accounting Firm for the Year 2026. | Audit-related | Board | AGAINST | 1 |
| PT TELKOM INDONESIA (PERSERO) TBK | 2026-06-08 | Determination of Public Accountant and/or Public Accounting Firm to Audit the Company's Consolidated Financial Statement and Company's Financial Report of the Micro and Small Business Funding Program (MSBF) for Financial Year of 2026. | Audit-related | Board | ABSTAIN | 1 |
| QUEST RESOURCE HOLDING CORPORATION | 2026-06-30 | To approve an amendment to our 2024 Incentive Compensation Plan (the "2024 Incentive Plan") to increase the number of shares available under our 2024 Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| RADNET, INC. | 2026-06-02 | The approval of an amendment and restatement to the Company's Equity Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| RAYMOND JAMES FINANCIAL, INC. | 2026-02-19 | To approve the Amended and Restated 2012 Stock Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| REGENERON PHARMACEUTICALS, INC. | 2026-06-12 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | Audit-related | Board | AGAINST | 1 |
| REGENXBIO INC. | 2026-05-29 | To approve a stock option exchange for our executive employees. | Compensation | Board | AGAINST | 1 |
| REGENXBIO INC. | 2026-05-29 | To approve a stock option exchange for our non-executive employees. | Compensation | Board | AGAINST | 1 |
| ROCKWELL AUTOMATION, INC. | 2026-02-10 | To approve the selection of Deloitte & Touche LLP as the Corporation's independent registered public accounting firm for fiscal 2026. | Audit-related | Board | AGAINST | 1 |
| SEMPRA | 2026-05-12 | Ratification of appointment of independent registered public accounting firm. | Audit-related | Board | AGAINST | 1 |
| SIGMAROC PLC | 2026-04-30 | TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 |
| SINGAPORE TELECOMMUNICATIONS LTD | 2025-07-29 | TO RE-ELECT DIRECTOR WHO RETIRE BY ROTATION IN ACCORDANCE WITH ARTICLE 100 OF THE CONSTITUTION OF THE COMPANY AND WHO, BEING ELIGIBLE, OFFER THEMSELVES FOR RE-ELECTION: MR JOHN LINDSAY ARTHUR | Director Elections | Board | AGAINST | 1 |
| SKYWORKS SOLUTIONS, INC. | 2026-05-13 | To approve the Company's 2026 Long-Term Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| SONOCO PRODUCTS COMPANY | 2026-04-15 | To approve Amendment No. 1 to the Sonoco Products Company 2024 Omnibus Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| SPIRE HEALTHCARE GROUP PLC | 2026-05-14 | AUTHORISE ISSUE OF EQUITY WITHOUT PRE-EMPTIVE RIGHTS | Capital Structure | Board | ABSTAIN | 1 |
| STELLANTIS N.V. | 2026-04-14 | Delegation to the Board of Directors of the authority to issue shares in the capital of the Company and to limit or to exclude pre- emptive rights: Proposal to designate the Board of Directors as the corporate body authorized to issue common shares and to grant rights to subscribe for common shares as provided for in article 7 of the Company's articles of association | Capital Structure | Board | ABSTAIN | 1 |
| STIFEL FINANCIAL CORP. | 2026-06-09 | To approve the adoption of an amendment to the Stifel Financial Corp. 2001 Incentive Stock Plan (2018 Restatement) | Compensation | Board | AGAINST | 1 |
| STMICROELECTRONICS N.V. | 2026-05-27 | Delegation to the Supervisory Board of the authority to issue new common shares, to grant rights to subscribe for such shares, and to limit and/or exclude existing shareholders' pre-emptive rights on common shares, until the conclusion of the Company's 2027 Annual General Meeting | Capital Structure | Board | ABSTAIN | 1 |
| STONERIDGE, INC. | 2026-05-19 | Approval of Amendment No. 1 to the 2025 Long-Term Incentive Plan to increase the number of shares available for issuance. | Compensation | Board | AGAINST | 1 |
| STV GROUP PLC | 2026-06-05 | TO APPROVE THE GRANT OF A ONE-OFF SHARE OPTION IN 2026 TO THE CHAIRMAN OF THE COMPANY | Compensation | Board | ABSTAIN | 1 |
| STV GROUP PLC | 2026-06-05 | TO APPROVE THE RULES OF THE STV GROUP PLC SHARE OPTION PLAN 2026 | Compensation | Board | ABSTAIN | 1 |
| STV GROUP PLC | 2026-06-05 | TO AUTHORISE THE DIRECTORS TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS IN RESPECT OF 5 PERCENT OF THE COMPANY'S ISSUED SHARE CAPITAL | Capital Structure | Board | ABSTAIN | 1 |
| SUN ART RETAIL GROUP LTD | 2025-08-14 | TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES HELD UNDER THE NAME OF THE COMPANY) IN THE CAPITAL OF THE COMPANY BY THE AGGREGATE NUMBER OF THE SHARES BOUGHT BACK BY THE COMPANY | Capital Structure | Board | AGAINST | 1 |
| SUN ART RETAIL GROUP LTD | 2025-08-14 | TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY (INCLUDING ANY SALE OR TRANSFER OF TREASURY SHARES HELD UNDER THE NAME OF THE COMPANY) NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES (EXCLUDING TREASURY SHARES, IF ANY) OF THE COMPANY AS AT THE DATE OF PASSING OF THIS RESOLUTION | Capital Structure | Board | AGAINST | 1 |
| SUN ART RETAIL GROUP LTD | 2025-08-14 | TO RE-ELECT MR. YIH LAI TAK, DIETER AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR | Director Elections | Board | AGAINST | 1 |
| SUN ART RETAIL GROUP LTD | 2025-08-14 | TO RE-ELECT MS. GUANNAN WANG AS A NON-EXECUTIVE DIRECTOR | Director Elections | Board | AGAINST | 1 |
| SUN ART RETAIL GROUP LTD | 2025-08-14 | TO RE-ELECT MS. MENGXUE MEI AS A NON-EXECUTIVE DIRECTOR | Director Elections | Board | AGAINST | 1 |
| SUNRISE COMMUNICATIONS AG | 2026-05-07 | ADVISORY VOTE ON THE COMPENSATION REPORT 2025 | Say-on-Pay | Board | ABSTAIN | 1 |
| SUPER MICRO COMPUTER INC. | 2026-04-15 | To approve the further amendment and restatement of the Super Micro Computer, Inc. 2020 Equity and Incentive Compensation Plan. | Compensation | Board | AGAINST | 1 |
| SUPER MICRO COMPUTER INC. | 2026-04-15 | To elect three Class I directors to hold office until the Annual Meeting of Stockholders following their year 2008 or until their successors are duly elected and qualified. Charles Liang | Director Elections | Board | ABSTAIN | 1 |
| SYNDAX PHARMACEUTICALS, INC | 2026-06-10 | To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| TECHNIPFMC PLC | 2026-05-01 | As a special resolution - Authority to Allot Equity Securities without Pre-emptive Rights: Pursuant to the authority contemplated by the resolution in Proposal 9, to authorize the Board to allot equity securities without pre-emptive rights. | Capital Structure | Board | AGAINST | 1 |
| TENCENT HOLDINGS LTD | 2026-05-13 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE NEW SHARES (ORDINARY RESOLUTION 5 AS SET OUT IN THE NOTICE OF THE AGM) | Capital Structure | Board | AGAINST | 1 |
| TEXAS INSTRUMENTS INCORPORATED | 2026-04-16 | Board proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. | Audit-related | Board | AGAINST | 1 |
| THE CHARLES SCHWAB CORPORATION | 2026-05-21 | Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for 2026 | Audit-related | Board | AGAINST | 1 |
| THE CIGNA GROUP | 2026-04-22 | Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2026 | Audit-related | Board | AGAINST | 1 |
| THE COCA-COLA COMPANY | 2026-04-29 | Ratify the appointment of Ernst & Young LLP as Independent Auditors of the Company to serve for the 2026 fiscal year | Audit-related | Board | AGAINST | 1 |
| THE MAGNUM ICE CREAM COMPANY N.V. | 2026-05-07 | Proposal to authorise the Board to restrict or exclude pre- emption rights in connection with the authorisations referred to in item 7(a) | Capital Structure | Board | ABSTAIN | 1 |
| THE TJX COMPANIES, INC. | 2026-06-09 | Ratification of appointment of PricewaterhouseCoopers as TJX's independent registered public accounting firm for fiscal 2027 | Audit-related | Board | AGAINST | 1 |
| THE TRADE DESK, INC. | 2025-09-16 | The approval of the amendment and restatement of the articles of incorporation of The Trade Desk, Inc. to change the date all of the shares of Class B common stock will automatically convert into Class A common stock and to waive jury trials for internal actions in conformity with recent Nevada law updates. | Capital Structure | Board | AGAINST | 1 |
| THE WALT DISNEY COMPANY | 2026-03-18 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for fiscal 2026. | Audit-related | Board | AGAINST | 1 |
| THE WENDY'S COMPANY | 2026-05-20 | Approve an amendment to the Company's 2020 Omnibus Award Plan to increase the number of shares of common stock available for issuance under the plan. | Compensation | Board | AGAINST | 1 |
| TRAVERE THERAPEUTICS, INC. | 2026-05-19 | To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. | Compensation | Board | ABSTAIN | 1 |
| TRINITY INDUSTRIES, INC. | 2026-05-21 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | ABSTAIN | 1 |
| TRUIST FINANCIAL CORPORATION | 2026-04-28 | Approval of the amendment and restatement of the Truist Financial Corporation 2022 Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| UNION PACIFIC CORPORATION | 2026-05-14 | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for 2026. | Audit-related | Board | AGAINST | 1 |
| UNIQURE N.V. | 2026-06-10 | Designation of the Board as the competent body to exclude or limit preemptive rights upon the issuance of Ordinary Shares. | Capital Structure | Board | AGAINST | 1 |
| UNIQURE N.V. | 2026-06-10 | Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. | Compensation | Board | AGAINST | 1 |
| UNITED NATURAL FOODS, INC. | 2025-12-16 | The approval of the Fifth Amended and Restated 2020 Equity Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| UNITED UTILITIES GROUP PLC | 2025-07-18 | TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 |
| VIASAT, INC. | 2025-09-04 | Amendment and Restatement of the 1996 Equity Participation Plan | Compensation | Board | AGAINST | 1 |
| VISTANCE NETWORKS, INC. | 2026-05-07 | Approval of additional shares under the Company's 2019 Long- Term Incentive Plan. | Compensation | Board | ABSTAIN | 1 |
| VIVENDI SE | 2026-04-21 | APPROVAL OF THE COMPONENTS OF COMPENSATION AND BENEFITS OF ANY KIND PAID DURING OR ALLOCATED FOR 2025 TO YANNICK BOLLORE, CHAIRMAN OF THE SUPERVISORY BOARD | Say-on-Pay | Board | ABSTAIN | 1 |
| VODAFONE GROUP PLC | 2025-07-29 | TO AUTHORISE THE DIRECTORS TO DIS-APPLY PRE- EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 |
| WASTE MANAGEMENT, INC. | 2026-05-12 | Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2026. | Audit-related | Board | AGAINST | 1 |
| WELLTOWER INC. | 2026-05-21 | The approval, on an advisory basis, of the compensation of the named executive officers. | Say-on-Pay | Board | ABSTAIN | 1 |
| WESTAIM CORP | 2026-05-19 | TO CONFIRM AND APPROVE THE AMENDED AND RESTATED LONG-TERM EQUITY INCENTIVE PLAN OF THE CORPORATION, AS REQUIRED BY THE TSX VENTURE EXCHANGE ON AN ANNUAL BASIS | Compensation | Board | ABSTAIN | 1 |
| WEX INC. | 2026-05-05 | The Company's proposal to approve on an advisory (non-binding) basis the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | ABSTAIN | 1 |
| WILLAMETTE VALLEY VINEYARDS, INC. | 2025-07-12 | Approval of the Company's 2025 Omnibus Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
| WILLIS TOWERS WATSON PLC | 2026-05-20 | Renew the Board's existing authority to opt out of statutory pre- emption rights under Irish law. | Capital Structure | Board | AGAINST | 1 |
| WINNEBAGO INDUSTRIES, INC. | 2025-12-16 | Approve our amended and restated 2019 Omnibus Incentive Plan | Compensation | Board | AGAINST | 1 |
| WOODSIDE ENERGY GROUP LTD | 2026-04-23 | Approval of Grant of FY26 LTI Award to CEO & Managing Director | Capital Structure | Board | ABSTAIN | 1 |
| WYNN MACAU LTD | 2026-05-28 | TO EXTEND THE GENERAL MANDATE GRANTED TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE AND DEAL WITH NEW SHARES OF THE COMPANY BY THE AGGREGATE NUMBER OF SHARES REPURCHASED BY THE COMPANY | Capital Structure | Board | AGAINST | 1 |
| WYNN MACAU LTD | 2026-05-28 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE AND DEAL WITH NEW SHARES OF THE COMPANY NOT EXCEEDING 20% OF THE TOTAL NUMBER OF ISSUED SHARES (INCLUDING ANY RESELL OR TRANSFER OF TREASURY SHARES HELD UNDER THE NAME OF THE COMPANY) OF THE COMPANY AS AT THE DATE OF PASSING OF THIS RESOLUTION (EXCLUDING TREASURY SHARES) | Capital Structure | Board | AGAINST | 1 |
| XENON PHARMACEUTICALS INC | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | Compensation | Board | ABSTAIN | 1 |
← Previous Page 5 of 5
← Back to Gabelli 2025-2026 overview
Built 2026-10-04 from SEC Form N-PX filings.